Sun Pharmaceuticals Recalls 10 Lakh Boxes Of Anti-Allergy Drug From US Market

by Shirley Johanna on  October 29, 2015 at 12:54 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Over ten lakh boxes of anti-allergic Loratadine drug has been recalled from the US market by Sun Pharmaceuticals as the lot was found to be 'super potent' and 'out of specification'.
Sun Pharmaceuticals Recalls 10 Lakh Boxes Of Anti-Allergy Drug From US Market
Sun Pharmaceuticals Recalls 10 Lakh Boxes Of Anti-Allergy Drug From US Market

As per the information available on the USFDA website, Ohm Laboratories Inc, a unit of Ranbaxy Laboratories, which the company acquired last year, is recalling 10,85,095 boxes for being "Superpotent Drug: Out Of Specification".

Sun Pharma had acquired Ranbaxy in a USD 4 billion deal last year making it the largest Indian pharma company by sales.

The recall was initiated on July 28 this year and has been put under Class-III which FDA defined as "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences".

Loratadine is an antihistamine and is used to treat the symptoms of allergies, such as sneezing, watery eyes, and runny nose.

Source: PTI 

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive